Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes

Lade...
Vorschaubild
Dateien
Fritsche_2-185v4z2k77bbf5.pdf
Fritsche_2-185v4z2k77bbf5.pdfGröße: 202.02 KBDownloads: 293
Datum
2018
Autor:innen
Fritsche, Ellen
Grandjean, Philippe
Crofton, Kevin M.
Aschner, Michael
Goldberg, Alan
Heinonen, Tuula
Hessel, Ellen V. S.
Hogberg, Helena T.
Bal-Price, Anna
et al.
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
European Union (EU): 681002
Projekt
EUToxRisk21
Open Access-Veröffentlichung
Open Access Hybrid
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Toxicology and applied pharmacology. 2018, 354, pp. 3-6. ISSN 0041-008X. eISSN 1096-0333. Available under: doi: 10.1016/j.taap.2018.02.004
Zusammenfassung

This consensus statement voices the agreement of scientific stakeholders from regulatory agencies, academia and industry that a new framework needs adopting for assessment of chemicals with the potential to disrupt brain development. An increased prevalence of neurodevelopmental disorders in children has been observed that cannot solely be explained by genetics and recently pre- and postnatal exposure to environmental chemicals has been suspected as a causal factor. There is only very limited information on neurodevelopmental toxicity, leaving thousands of chemicals, that are present in the environment, with high uncertainty concerning their developmental neurotoxicity (DNT) potential. Closing this data gap with the current test guideline approach is not feasible, because the in vivo bioassays are far too resource-intensive concerning time, money and number of animals. A variety of in vitro methods are now available, that have the potential to close this data gap by permitting mode-of-action-based DNT testing employing human stem cells-derived neuronal/glial models. In vitro DNT data together with in silico approaches will in the future allow development of predictive models for DNT effects. The ultimate application goals of these new approach methods for DNT testing are their usage for different regulatory purposes.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Developmental neurotoxicity, In vitro testing, Regulatory purposes
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690FRITSCHE, Ellen, Philippe GRANDJEAN, Kevin M. CROFTON, Michael ASCHNER, Alan GOLDBERG, Tuula HEINONEN, Ellen V. S. HESSEL, Helena T. HOGBERG, Marcel LEIST, Anna BAL-PRICE, 2018. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes. In: Toxicology and applied pharmacology. 2018, 354, pp. 3-6. ISSN 0041-008X. eISSN 1096-0333. Available under: doi: 10.1016/j.taap.2018.02.004
BibTex
@article{Fritsche2018-09Conse-41618,
  year={2018},
  doi={10.1016/j.taap.2018.02.004},
  title={Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes},
  volume={354},
  issn={0041-008X},
  journal={Toxicology and applied pharmacology},
  pages={3--6},
  author={Fritsche, Ellen and Grandjean, Philippe and Crofton, Kevin M. and Aschner, Michael and Goldberg, Alan and Heinonen, Tuula and Hessel, Ellen V. S. and Hogberg, Helena T. and Leist, Marcel and Bal-Price, Anna}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/41618">
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-02-27T14:36:27Z</dcterms:available>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dc:contributor>Hessel, Ellen V. S.</dc:contributor>
    <dcterms:abstract xml:lang="eng">This consensus statement voices the agreement of scientific stakeholders from regulatory agencies, academia and industry that a new framework needs adopting for assessment of chemicals with the potential to disrupt brain development. An increased prevalence of neurodevelopmental disorders in children has been observed that cannot solely be explained by genetics and recently pre- and postnatal exposure to environmental chemicals has been suspected as a causal factor. There is only very limited information on neurodevelopmental toxicity, leaving thousands of chemicals, that are present in the environment, with high uncertainty concerning their developmental neurotoxicity (DNT) potential. Closing this data gap with the current test guideline approach is not feasible, because the in vivo bioassays are far too resource-intensive concerning time, money and number of animals. A variety of in vitro methods are now available, that have the potential to close this data gap by permitting mode-of-action-based DNT testing employing human stem cells-derived neuronal/glial models. In vitro DNT data together with in silico approaches will in the future allow development of predictive models for DNT effects. The ultimate application goals of these new approach methods for DNT testing are their usage for different regulatory purposes.</dcterms:abstract>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:creator>Aschner, Michael</dc:creator>
    <dc:creator>Heinonen, Tuula</dc:creator>
    <dc:contributor>Crofton, Kevin M.</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-02-27T14:36:27Z</dc:date>
    <dcterms:issued>2018-09</dcterms:issued>
    <dc:creator>Hessel, Ellen V. S.</dc:creator>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Grandjean, Philippe</dc:contributor>
    <dc:contributor>Goldberg, Alan</dc:contributor>
    <dc:creator>Grandjean, Philippe</dc:creator>
    <dc:creator>Goldberg, Alan</dc:creator>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:title>Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes</dcterms:title>
    <dc:contributor>Hogberg, Helena T.</dc:contributor>
    <dc:creator>Fritsche, Ellen</dc:creator>
    <dc:contributor>Aschner, Michael</dc:contributor>
    <dc:creator>Leist, Marcel</dc:creator>
    <dc:contributor>Fritsche, Ellen</dc:contributor>
    <dc:contributor>Heinonen, Tuula</dc:contributor>
    <dc:creator>Crofton, Kevin M.</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:language>eng</dc:language>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/41618/1/Fritsche_2-185v4z2k77bbf5.pdf"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/41618/1/Fritsche_2-185v4z2k77bbf5.pdf"/>
    <dc:contributor>Bal-Price, Anna</dc:contributor>
    <dc:creator>Bal-Price, Anna</dc:creator>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/41618"/>
    <dc:creator>Hogberg, Helena T.</dc:creator>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen